Cargando…

Genetic Variability of HIV-1 for Drug Resistance Assay Development

A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- and middle-income countries (LMICs) where resistance testing is not routinely available. The major obstacle in developing such an assay is the extreme genetic variability of HIV-1. We analyzed 27,203 re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clutter, Dana S., Sánchez, Patricia Rojas, Rhee, Soo-Yon, Shafer, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776203/ https://www.ncbi.nlm.nih.gov/pubmed/26875985 http://dx.doi.org/10.3390/v8020048

Ejemplares similares

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2021)

Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance
por: Clutter, Dana S., et al.
Publicado: (2016)

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population
por: Rhee, Soo-Yon, et al.
Publicado: (2019)

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2016)

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2023)

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
por: Gifford, Robert J., et al.
Publicado: (2009)

Correction: More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2017)

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis
por: Avila-Rios, Santiago, et al.
Publicado: (2016)

Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences
por: Rhee, Soo-Yon, et al.
Publicado: (2018)

HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates
por: Rhee, Soo‐Yon, et al.
Publicado: (2020)

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
por: Blanco, Jose-Luis, et al.
Publicado: (2011)

HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing
por: Tao, Kaiming, et al.
Publicado: (2023)

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
por: Reuman, Elizabeth C., et al.
Publicado: (2010)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

HIV-1 Subtype B Protease and Reverse Transcriptase Amino Acid Covariation
por: Rhee, Soo-Yon, et al.
Publicado: (2007)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
por: Doherty, Kathleen M, et al.
Publicado: (2011)

A systematic review of the genetic mechanisms of dolutegravir resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2019)

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations
por: Nouhin, Janin, et al.
Publicado: (2023)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
por: Tao, Kaiming, et al.
Publicado: (2023)

Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy
por: Tzou, Philip L., et al.
Publicado: (2018)

Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
por: Kapoor, Amit, et al.
Publicado: (2008)

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C
por: Margeridon-Thermet, Severine, et al.
Publicado: (2010)

Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations
por: Johnson, Jeffrey A., et al.
Publicado: (2007)

Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
por: Rhee, Soo-Yon, et al.
Publicado: (2008)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system
por: T. Tchakoute, Christophe, et al.
Publicado: (2022)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)

Functional conservation of HIV-1 Gag: implications for rational drug design
por: Li, Guangdi, et al.
Publicado: (2013)

A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT)
por: DeVos, Joshua, et al.
Publicado: (2022)

Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications
por: Tang, Michele W., et al.
Publicado: (2012)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants
por: Zhu, Qinchang, et al.
Publicado: (2015)

HIV Genetic Diversity and Drug Resistance
por: Santos, André F., et al.
Publicado: (2010)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
por: Noguera-Julian, Marc, et al.
Publicado: (2020)

Recommendations on data sharing in HIV drug resistance research
por: Inzaule, Seth C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nb6rmllr8db5ugdlf4ip9797ri